Longevity PapersAbout
← All papers
RESEARCH PAPER / 2024-08-21

Unlocking mitochondrial dysfunction-associated senescence (MiDAS) with NAD

Herbert Sizek, Dávid Deritei, Katherine Fleig, Marlayna Harris, Peter L Regan, Kimberly Glass, Erzsébet Ravasz Regan

Biochemistry and Molecular Biology, The College of Wooster, Wooster, OH 44691, USA.Biochemistry and Molecular Biology, The College of Wooster, Wooster, OH 44691, USA. · pubmed

Abstract

The steady accumulation of senescent cells with aging creates tissue environments that aid cancer evolution. Aging cell states are highly heterogeneous. 'Deep senescent' cells rely on healthy mitochondria to fuel a strong proinflammatory secretome, including cytokines, growth and transforming signals. Yet, the physiological triggers of senescence such as reactive oxygen species (ROS) can also trigger mitochondrial dysfunction, and sufficient energy deficit to alter their secretome and cause chronic oxidative stress - a state termed Mitochondrial Dysfunction-Associated Senescence (MiDAS). Here, we offer a mechanistic hypothesis for the molecular processes leading to MiDAS, along with testable predictions. To do this we have built a Boolean regulatory network model that qualitatively captures key aspects of mitochondrial dynamics during cell cycle progression (hyper-fusion at the G1/S boundary, fission in mitosis), apoptosis (fission and dysfunction) and glucose starvation (reversible hyper-fusion), as well as MiDAS in response to SIRT3 knockdown or oxidative stress. Our model reaffirms the protective role of NAD

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper addresses mitochondrial dysfunction and its role in cellular senescence, which are key factors in the aging process. By proposing a mechanistic hypothesis for Mitochondrial Dysfunction-Associated Senescence (MiDAS) and exploring the role of NAD, it contributes to understanding the underlying mechanisms of aging rather than merely addressing symptoms. However, while the research is solid, it does not present groundbreaking findings that would significantly advance the field, hence the moderate impact score.

Author of this paper? Send a correction.